A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015) (NCT06979596)
A Multicenter, Open-label, Phase 2 Basket Study of MK-5684 in Participants With Selected Solid Tumors (OMAHA-015)
🩺 Plain-English Summary (8th-Grade Level)
Researchers want to learn if MK-5684 (the study medicine) can treat breast cancer, ovarian cancer, and endometrial cancer. MK-5684, the study medicine, is designed to treat cancer by blocking the body from making steroid hormones. Researchers will compare MK-5684 to the standard treatments for each cancer type in this study. The goal of this study is to learn if people who receive MK-5684 live longer without the cancer growing or spreading compared to people who receive a standard treatment.
Who can join: Review the eligibility criteria below.
Location: Alaska Womens Cancer Care ( Site 0037) — Anchorage, Alaska
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (59 Sites)
Showing the first 25 of 59 sites.
- Alaska Womens Cancer Care ( Site 0037) — Anchorage, Alaska
- Mount Sinai Cancer Center ( Site 0009) — Miami Beach, Florida
- TRIALS 365 ( Site 0022) — Shreveport, Louisiana
- Mary Lanning Healthcare ( Site 0019) — Hastings, Nebraska
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0021) — Hackensack, New Jersey
- Rockefeller Outpatient Pavilion ( Site 0002) — New York, New York
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008) — Columbus, Ohio
- Baylor College of Medicine Medical Center ( Site 0004) — Houston, Texas
- Harris Health System ( Site 0040) — Houston, Texas
- Mays Cancer Center ( Site 0039) — San Antonio, Texas
- Hospital Aleman ( Site 0301) — Ciudad Autonoma de Buenos Aires, Buenos Aires
- Centro Medico Dr. Doreski - Fundación Respirar ( Site 0302) — Buenos Aires, Buenos Aires F.D.
- Instituto Alexander Fleming ( Site 0303) — Buenos Aires, Buenos Aires F.D.
- Hospital Santa Rita de Cassia ( Site 3104) — Vitória, Espírito Santo
- Obras Sociais Irma Dulce ( Site 3112) — Salvador, Estado de Bahia
- Hospital Felicio Rocho ( Site 3105) — Belo Horizonte, Minas Gerais
- Hospital de Cancer de Pernambuco ( Site 3103) — Recife, Pernambuco
- Liga Norte Riograndense Contra o Cancer ( Site 3108) — Natal, Rio Grande do Norte
- Instituto Nacional de Câncer - INCA ( Site 3107) — Rio de Janeiro,
- Princess Margaret Cancer Centre ( Site 0202) — Toronto, Ontario
- Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0200) — Montreal, Quebec
- Jewish General Hospital ( Site 0201) — Montreal, Quebec
- Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer ( Site 0205) — Sherbrooke, Quebec
- FALP ( Site 3300) — Santiago, Region M. de Santiago
- Pontificia Universidad Catolica de Chile ( Site 3307) — Santiago, Region M. de Santiago
📞 Contact the Study Coordinator
Phone: (888) 577-8839
Email: Trialsites@msd.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Malignant Neoplasm
- Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment — Duarte, California
- Reproductive Health Program in Patients With Cancer — Jonesboro, Arkansas
- rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy — Houston, Texas
- Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer — Newark, Delaware
- Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families — Houston, Texas
- Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies — Los Angeles, California
Explore by condition: All Malignant Neoplasm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.